Parametric Portfolio Associates’s BioAtla BCAB Stock Holding History

Parametric Portfolio Associates’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$135K	Buy	+540	New	+$226K	﹤0.01%	3516

Other funds holding BCAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Parametric Portfolio Associates's BCAB Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in BioAtla (BCAB) in Q1 2022: 540 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #3516 among its holdings.

97 funds tracked by Wall St. Rank hold BCAB as of Q1 2022.

Parametric Portfolio Associates held 540 shares of BioAtla worth $135K as of Q1 2022.
BioAtla was a new Parametric Portfolio Associates position in Q1 2022.
BioAtla made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3516 holding.
97 funds tracked by Wall St. Rank held BioAtla as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.